Takeda is buying Ariad Pharmaceuticals in a $5.2 billion deal

Here’s the press release: CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) (“Ariad”) today announced that they have entered into a definitive …
( read original story …)